Monthly information on share capital and company voting rights
Cellectis (CLLS) has released its monthly share capital and voting rights report as required by Article 223-16 of the French financial markets authority's General Regulation. The company's shares are listed on Euronext Growth under ISIN code FR0010425595.
Cellectis (CLLS) ha pubblicato il suo rapporto mensile sul capitale sociale e sui diritti di voto, come richiesto dall'Articolo 223-16 del Regolamento Generale dell'autorità dei mercati finanziari francese. Le azioni della società sono quotate su Euronext Growth con il codice ISIN FR0010425595.
Cellectis (CLLS) ha publicado su informe mensual sobre el capital social y los derechos de voto, como lo exige el Artículo 223-16 del Reglamento General de la autoridad de los mercados financieros de Francia. Las acciones de la compañía están listadas en Euronext Growth bajo el código ISIN FR0010425595.
Cellectis (CLLS)는 프랑스 금융 시장 당국의 일반 규정 제223-16조에 따라 월간 자본금 및 의결권 보고서를 발표했습니다. 회사의 주식은 ISIN 코드 FR0010425595로 Euronext Growth에 상장되어 있습니다.
Cellectis (CLLS) a publié son rapport mensuel sur le capital social et les droits de vote, comme l'exige l'Article 223-16 du Règlement Général de l'autorité des marchés financiers français. Les actions de la société sont cotées sur Euronext Growth sous le code ISIN FR0010425595.
Cellectis (CLLS) hat seinen monatlichen Bericht über das Grundkapital und die Stimmrechte veröffentlicht, wie es Artikel 223-16 der allgemeinen Vorschriften der französischen Finanzmarktaufsicht vorschreibt. Die Aktien des Unternehmens sind unter der ISIN-Nummer FR0010425595 an Euronext Growth notiert.
- None.
- None.
(Article 223-16 of General Regulation of the French financial markets authority)
PARIS, March 06, 2025 (GLOBE NEWSWIRE) --
Listing market: Euronext Growth
ISIN code: FR0010425595
| Date | Total number of shares in the capital | Total number of voting rights |
| 02/28/2025 | 100,093,873 | 88,849,752 |
For further information on Cellectis, please contact:
Media contacts:
Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com
Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93
Investor Relations contact:
Arthur Stril, Chief Financial Officer & Chief Business Officer, investors@cellectis.com
Attachment
FAQ
What regulatory requirement is Cellectis (CLLS) fulfilling with this announcement?
Where are Cellectis (CLLS) shares listed for trading?
When was this share capital and voting rights report released by Cellectis (CLLS)?
Who are the key contacts for Cellectis (CLLS) investor relations?
